In this video update, COO and President, Matthew Mills reviews the year-end Company progress and outlines how this momentum will potentially set the Company up in 2021.
2020 was a challenging year for everyone including Med-X. We faced all the challenges head-on and even during this global pandemic, of the likes few living people have ever endured, we still balanced the Company and grew revenue to over 1 million dollars.
This milestone was a challenging accomplishment for our team and we are very grateful to all of our shareholders for the support and encouragement during these unusual times.
Our products reached more customers than ever before and our positions in our major distribution channels and our Ecommerce positioning has finally matured. The hard work and focus on customer service has paid off in the way of loyal returning customers and positive reviews both fueling our multiple brand’s growth.
In 2021 we plan to continue to optimize our current direct-to-consumer sales as well as expand our reach by utilizing several other big-box platforms that will hopefully generate more online revenue and introduce the products to more customers and corporate buyers in the hopes of also broadening our brick and mortar retail positions in a positive manner.
Due to a continued Ecommerce growth run in 2020, we have already been approved to sell on Walmart.com and we are working on gaining further positioning with Homedepot.com, Lowes.com, Acehardware.com, Tractorsupply.com as well as several other Large Retailers and Grocery Outlets.
With our engagements with Eurasian Capital, US Capital Global, and now the New Chip Accelerator program, we hope to start showcasing the Med-X business model to large scale investors worldwide, from our global marketing rollout that is expected to materialize during the beginning of the first quarter of 2021.
The continued support from our shareholders has propelled the Company past the 2 million dollar crowdfunding milestone with now over 600 investors in this Offering alone.
This support has given us the funds to lock in 2021 marketing plans and inventory as well as to potentially expand our offerings by creating new and exciting SKU’s from all of our brand divisions.
Together with over 3,500 engaged individual shareholders our project appears to be a target for other larger investors to get on board. So it's important to continue spreading the word about the Med-X investment opportunity to family, friends and colleagues.
The business trends we saw many years ago are again taking shape, except this time around, Med-X is defying the global landscape and has taken an organically grown position as an essential business supplier, and is continuing growth during the most unpredictable times we have ever seen in modern history.
We, as a management team, expect this to continue as new customers are engaging through our networks on a weekly basis.
We hope all of you have a safe and healthy New Years Holiday.
We toast to each one of you who have believed in this project, our team, and to the bright future ahead of us together.
Cheers and Happy New Year
DISCLAIMER AND FORWARD-LOOKING STATEMENTS
The securities offered by Med-X, Inc. hereby are highly speculative. Investing in shares of MED-X, INC. involves significant risk. This investment is suitable only for persons who can afford to lose their entire investment. Furthermore, investors must understand that an investment could be illiquid for an indefinite period of time. No public market currently exists for the securities and if and when a public market develops following this offering it may not continue. You should read the NEW Offering Circular as well as all Securities Exchange Commission filings before making any investment in the Company.
This release may contain forward-looking statements regarding projected business performance, operating results, financial condition and other aspects of the company, expressed by such language as "expected," "anticipated," "projected" and "forecasted." Please be advised that such statements are estimates only and there is no assurance that the results stated or implied by forward-looking statements will actually be realized by the company. Forward-looking statements may be based on management assumptions that prove to be wrong. The company and its business are subject to substantial risks and potential events beyond its control that would cause material differences between predicted results and actual results, including the company incurring operating losses and experiencing unexpected material adverse events.